Dr. Moyad has been the driving force behind getting the Early Access Program for drugs to treat advanced prostate cancer. Along with the Early Access Committee he has arranged for an early access (before the formal approval from the FDA) for both Zytiga and now MDV3100. (you can read about the programs including how to [...]
I wanted to let everyone know that over the next two weeks my posts might become few and far between. Iaa am traveling with my family in Alaska where my ability to find either internet or cell connections has become difficult. I will attempt to find an occasional connection and put something up. I will [...]
The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced [...]
When the press discusses medical mistakes they are usually referring to mistakes made in a hospital, but guess what, mistakes are often made in a doctors office. These mistakes are not counted in the statistics often quoted. Twelve year old data from the Institute of Medicine sites the horrific statistic that each year between 44,000 [...]
A new randomized study (FinnProstate Study VII) on the merits of intermittent androgen deprivation (IAD) compared to continuous androgen therapy (CAD) contradicts the recent revelations from the last ASCO presentation (Hussain et.al) where the clear conclusion was that CAD was superior to IAD. At the ASCO conference Dr. Hussain’s study concluded that IAD was significantly [...]